Stanford's milli-spinner and ETH Zurich's microrobot systems represent clinically ready platforms for steering magnetic microrobots using standard fluoroscopy and X-ray imaging to target blood clots in vessels where conventional thrombectomy fails in 10-30% of cases. The systems are being developed to navigate areas inaccessible to catheters, addressing a significant clinical gap in stroke and thrombotic interventions. This represents a major shift toward untethered robotic systems in minimally invasive surgery, pending resolution of regulatory frameworks for tracking, retrieval, and liability.